Orchid Pharma Limited Stock Bombay S.E.
Equities
524372
INE191A01019
Pharmaceuticals
Sales 2024 * | 8.45B 101M | Sales 2025 * | 10.78B 129M | Capitalization | 52.48B 628M |
---|---|---|---|---|---|
Net income 2024 * | 908M 10.87M | Net income 2025 * | 1.42B 17.03M | EV / Sales 2024 * | 6.09 x |
Net cash position 2024 * | 1.06B 12.65M | Net cash position 2025 * | 1.2B 14.34M | EV / Sales 2025 * | 4.76 x |
P/E ratio 2024 * |
57.4
x | P/E ratio 2025 * |
37
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
Director of Finance/CFO | - | 20-06-28 | |
Kapil Dayya
CMP | Compliance Officer | - | Dec. 15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 20-03-30 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 20-03-30 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 20-03-30 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+29.22% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.85% | 240B | |
+9.18% | 208B | |
-7.85% | 200B | |
+7.68% | 166B |